Risk Factors for Cerebral Aneurysm Rupture in Mongolia.


Journal

Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 25 02 2021
accepted: 31 05 2021
pubmed: 1 7 2021
medline: 15 6 2022
entrez: 30 6 2021
Statut: ppublish

Résumé

Identification of country-specific demographic, medical, lifestyle, and geoenvironmental risk factors for cerebral aneurysm rupture in the developing Asian country of Mongolia. First-time estimation of the crude national incidence of aneurysmal subarachnoid hemorrhage (aSAH). A retrospective analysis of all intracranial digital subtraction angiographies (DSA) acquired in Mongolia during the 2‑year period 2016-2017 (1714 examinations) was performed. During this period, DSA was used as primary diagnostic imaging modality for acute severe neurological symptoms in the sole hospital nationwide dedicated to neurological patients. The catchment area of the hospital included the whole country. Patients with incidental and ruptured aneurysms were reviewed with respect to their medical history and living conditions. The data was used to install a Mongolian aneurysm registry. The estimated annual crude incidence of cerebral aneurysm rupture was 6.71 for the country of Mongolia and 14.53 per 100,000 persons for the capital region of Ulaanbaatar. Risk factors common in developed countries also applied for the Mongolian population: A medical history of hypertension, smoking or the presence of multiple aneurysms led to a higher relative risk of rupture. In contrast, female gender was not associated with a higher risk in this national cohort. Males pursuing a traditional nomadic living may exhibit a specifically high risk of rupture. Disease management of over 200 individuals/year with aSAH constitutes a socioeconomic burden in Mongolia. Efforts to raise awareness of the risk factors hypertension and smoking among the Mongolian population are desirable. Measures to improve the nationwide availability of modern neurovascular treatment options are currently under consideration.

Identifiants

pubmed: 34191041
doi: 10.1007/s00062-021-01051-z
pii: 10.1007/s00062-021-01051-z
pmc: PMC9187534
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

499-506

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : BE 6787/1-1
Organisme : Deutsche Forschungsgemeinschaft
ID : SE 2052/3-1

Informations de copyright

© 2021. The Author(s).

Références

World Neurosurg. 2017 Jun;102:191-199
pubmed: 28254543
Lancet Neurol. 2014 Jan;13(1):59-66
pubmed: 24290159
N Engl J Med. 2012 Jun 28;366(26):2474-82
pubmed: 22738097
J Neurol Neurosurg Psychiatry. 2021 May;92(5):542-548
pubmed: 33148817
Stroke. 2010 Sep;41(9):1969-77
pubmed: 20671254
Asia Pac Allergy. 2014 Jan;4(1):25-31
pubmed: 24527407
Lancet Respir Med. 2017 Aug;5(8):614-615
pubmed: 28669557
Int J Stroke. 2020 Oct;15(8):819-838
pubmed: 32146867
J Clin Hypertens (Greenwich). 2020 Jan;22(1):103-110
pubmed: 31913578
Ann Am Thorac Soc. 2018 Apr;15(Suppl 2):S86-S90
pubmed: 29676634
World Neurosurg. 2018 Jul;115:430-447.e7
pubmed: 29649643
Interv Neuroradiol. 2021 Feb;27(1):42-50
pubmed: 32640858
J Neurointerv Surg. 2019 Mar;11(3):320-322
pubmed: 30314993
Neuroepidemiology. 2015;45(3):161-76
pubmed: 26505981
Stroke. 2013 Sep;44(9):2414-21
pubmed: 23868274
Lancet. 2003 Jul 12;362(9378):103-10
pubmed: 12867109
J Stroke. 2016 Sep;18(3):321-327
pubmed: 27488981
JAMA Neurol. 2019 May 1;76(5):588-597
pubmed: 30659573
Lancet Glob Health. 2013 Nov;1(5):e259-81
pubmed: 25104492
Neurology. 2016 Sep 13;87(11):1118-23
pubmed: 27521438
Air Qual Atmos Health. 2013 Mar;6(1):137-150
pubmed: 23450113
Clin Neuroradiol. 2019 Mar;29(1):125-133
pubmed: 29080036
Neurology. 2017 Sep 26;89(13):1408-1415
pubmed: 28855408
Stroke. 2009 Jan;40(1):313-6
pubmed: 18845802

Auteurs

Matthias Bechstein (M)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. m.bechstein@uke.de.

Amarjargal Gansukh (A)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Mongolian Academy of Sciences, Oyun Onosh Medical Center, Ulaanbaatar, Mongolia.

Boldbat Regzengombo (B)

Mongolian Academy of Sciences, Oyun Onosh Medical Center, Ulaanbaatar, Mongolia.
Shastin Central Hospital, Ulaanbaatar, Mongolia.

Oyun Byambajav (O)

Mongolian Academy of Sciences, Oyun Onosh Medical Center, Ulaanbaatar, Mongolia.
Shastin Central Hospital, Ulaanbaatar, Mongolia.

Lukas Meyer (L)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Michael Schönfeld (M)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Helge Kniep (H)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Uta Hanning (U)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Gabriel Broocks (G)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Tserenchunt Gansukh (T)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Mongolian Academy of Sciences, Oyun Onosh Medical Center, Ulaanbaatar, Mongolia.

Jens Fiehler (J)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH